Abstract
The concentration of lysophospholipids (LPL) increases under pathological conditions and, thus, LPL attract diagnostic and pharmacological interest. LPL are particularly interesting because they possess pro- and anti-inflammatory properties and can be generated by phospholipases and reactive oxygen species (ROS). This review provides an overview of the mechanisms by which LPL are generated and how they can be determined. The effects of LPL as signaling molecules and their roles in different pathologies are discussed. The focus will be on lysophosphatidylcholine (LPC).
Keywords: Lysophospholipids, Phospholipids, Lysophosphatidylcholine, Phospholipase, Reactive Oxygen Species, Inflammation, Disease Markers, Signaling Molecules
Mini-Reviews in Medicinal Chemistry
Title: Lysophospholipids: Their Generation, Physiological Role and Detection. Are They Important Disease Markers?
Volume: 9 Issue: 3
Author(s): Beate Fuchs and Jurgen Schiller
Affiliation:
Keywords: Lysophospholipids, Phospholipids, Lysophosphatidylcholine, Phospholipase, Reactive Oxygen Species, Inflammation, Disease Markers, Signaling Molecules
Abstract: The concentration of lysophospholipids (LPL) increases under pathological conditions and, thus, LPL attract diagnostic and pharmacological interest. LPL are particularly interesting because they possess pro- and anti-inflammatory properties and can be generated by phospholipases and reactive oxygen species (ROS). This review provides an overview of the mechanisms by which LPL are generated and how they can be determined. The effects of LPL as signaling molecules and their roles in different pathologies are discussed. The focus will be on lysophosphatidylcholine (LPC).
Export Options
About this article
Cite this article as:
Fuchs Beate and Schiller Jurgen, Lysophospholipids: Their Generation, Physiological Role and Detection. Are They Important Disease Markers?, Mini-Reviews in Medicinal Chemistry 2009; 9 (3) . https://dx.doi.org/10.2174/1389557510909030368
DOI https://dx.doi.org/10.2174/1389557510909030368 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews Podocytes as Target of Vitamin D
Current Diabetes Reviews Angiotensin II: Role in Skeletal Muscle Atrophy
Current Protein & Peptide Science Transplantation-Based Gene Therapy for Inflammatory Diseases Focus on Glomerulonephritis
Current Gene Therapy Vitamin D Replacement and Type 2 Diabetes Mellitus
Current Diabetes Reviews Resurgence of Herbal Antihypertensives in Management of Hypertension
Current Hypertension Reviews Allopurinol Hypersensitivity Reactions: Desensitization Strategies and New Therapeutic Alternative Molecules
Inflammation & Allergy - Drug Targets (Discontinued) NF-κB and Proteinuric Renal Disease
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System
Current Pharmaceutical Design SAGE Application in the Study of Diabetes
Current Pharmaceutical Biotechnology CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
Current Gene Therapy Renoprotection with Anti-Hypertensives: Reduction of Proteinuria and Improvement of Oxygenation via Inhibition of the Renin-Angiotensin System
Current Hypertension Reviews The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets Pathophysiology of Diabetic Dyslipidaemia
Current Vascular Pharmacology The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Renal Artery Stenting: Efficacy and Complications
Current Hypertension Reviews Editorial [Hot Topic: Pathogenesis and Treatment of Diabetic Complications,Retinopathy, Nephropathy and Cardiomyopathy (Executive Editor: J.L. Wilkinson-Berka)]
Current Pharmaceutical Design Phyto-glycosides as Therapeutic Target in the Treatment of Diabetes
Mini-Reviews in Medicinal Chemistry Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets